Inflammasome Formation in Granulomas in Cardiac Sarcoidosis.
作者信息
Kron Jordana, Mauro Adolfo Gabriele, Bonaventura Aldo, Toldo Stefano, Salloum Fadi N, Ellenbogen Kenneth A, Abbate Antonio
机构信息
Pauley Heart Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond (J.K., A.G.M., A.B., S.T., F.N.S., K.A.E., A.A.).
First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Italy (A.B.).
出版信息
Circ Arrhythm Electrophysiol. 2019 Sep;12(9):e007582. doi: 10.1161/CIRCEP.119.007582. Epub 2019 Sep 16.
Abstract
摘要
相似文献
1
Inflammasome Formation in Granulomas in Cardiac Sarcoidosis.心脏结节病肉芽肿中的炎性小体形成
Circ Arrhythm Electrophysiol. 2019 Sep;12(9):e007582. doi: 10.1161/CIRCEP.119.007582. Epub 2019 Sep 16.
2
Cardiac sarcoidosis with presentation of large left atrial mass.
Curr Opin Pulm Med. 2004 Sep;10(5):397-400. doi: 10.1097/01.mcp.0000136403.32451.aa.
3
Myocardial Accumulations of Reg3A, Reg3γ and Oncostatin M Are Associated with the Formation of Granulomata in Patients with Cardiac Sarcoidosis.心肌中 Reg3A、Reg3γ 和 Oncostatin M 的蓄积与心脏结节病患者肉芽肿的形成有关。
Int J Mol Sci. 2021 Apr 16;22(8):4148. doi: 10.3390/ijms22084148.
4
Diagnostic Value of PET in Cardiac Sarcoidosis.PET在心脏结节病中的诊断价值。
J Nucl Med. 2004 Nov;45(11):1975.
5
Diagnosed late cardiac sarcoidosis in a patient with atrioventricular block.一名患有房室传导阻滞的患者被诊断为晚期心脏结节病。
Br J Hosp Med (Lond). 2016 Nov 2;77(11):658-659. doi: 10.12968/hmed.2016.77.11.658.
6
Cytological identification of Schaumann bodies within granulomas clinches the diagnosis of sarcoidosis.
Cytopathology. 2018 Apr;29(2):213-214. doi: 10.1111/cyt.12487. Epub 2017 Nov 9.
7
Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis.用于评估心脏结节病的氟代脱氧葡萄糖正电子发射断层扫描的可重复性与优化
JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1284-1287. doi: 10.1016/j.jcmg.2019.01.011. Epub 2019 Mar 4.
8
Heart block in a 60-year-old man with undiagnosed cardiac sarcoidosis.一名60岁未确诊心脏结节病男性的心脏传导阻滞。
CMAJ. 2022 Feb 28;194(8):E306-E309. doi: 10.1503/cmaj.211149.
9
Cardiac Sarcoidosis Masked by Malignant Lymphoma.恶性淋巴瘤掩盖下的心肌结节病。
Can J Cardiol. 2016 Aug;32(8):1039.e11-3. doi: 10.1016/j.cjca.2015.09.014. Epub 2015 Sep 26.
10
Correlation of inflammation due to cardiac sarcoidosis by positron emission tomography-computed tomography imaging and endocardial voltage mapping in a patient with recurrent ventricular tachycardia.一名复发性室性心动过速患者中，正电子发射断层扫描-计算机断层扫描成像显示的心脏结节病所致炎症与心内膜电压标测的相关性
Europace. 2014 Jun;16(6):907. doi: 10.1093/europace/euu052. Epub 2014 Apr 1.
引用本文的文献
1
Transcriptomic profiling of granuloma in patients with cardiac sarcoidosis.心脏结节病患者肉芽肿的转录组分析
Theranostics. 2025 Apr 28;15(13):6044-6057. doi: 10.7150/thno.109211. eCollection 2025.
2
Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases.针对心血管疾病炎症的新型治疗方法和即将开展的临床试验。
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2371-2395. doi: 10.1161/ATVBAHA.124.319980. Epub 2024 Oct 10.
3
Cardiac Involvement in Patients With Multisystem Inflammatory Syndrome in Adults.成人多系统炎症综合征患者的心脏受累情况
J Am Heart Assoc. 2024 Feb 20;13(4):e032143. doi: 10.1161/JAHA.123.032143. Epub 2024 Feb 13.
4
The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases.NLRP3 炎性小体与细胞焦亡在心血管疾病中的作用。
Nat Rev Cardiol. 2024 Apr;21(4):219-237. doi: 10.1038/s41569-023-00946-3. Epub 2023 Nov 3.
5
Interleukin-1 Inhibition for the Prevention and Treatment of Heart Failure.白细胞介素-1 抑制在心力衰竭预防和治疗中的作用。
J Cardiovasc Pharmacol. 2024 Jun 1;83(6):522-530. doi: 10.1097/FJC.0000000000001497.
6
Interleukin-1 Blockade in Cardiac Sarcoidosis: A Pilot Study.心脏结节病中白细胞介素-1阻断：一项初步研究。
Circ Arrhythm Electrophysiol. 2023 May;16(5):e011869. doi: 10.1161/CIRCEP.123.011869. Epub 2023 Apr 24.
7
Identifying Inflammasome Activation in Human Tissues.
Methods Mol Biol. 2023;2641:101-113. doi: 10.1007/978-1-0716-3040-2_8.
8
Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches.结节病：治疗药物试验及新治疗方法的最新进展
Front Med (Lausanne). 2022 Oct 12;9:991783. doi: 10.3389/fmed.2022.991783. eCollection 2022.
9
The inflammasome in heart failure.心力衰竭中的炎性小体。
Curr Opin Physiol. 2021 Feb;19:105-112. doi: 10.1016/j.cophys.2020.09.013. Epub 2020 Oct 7.
10
Targeting the NLRP3 inflammasome in cardiovascular diseases.针对心血管疾病中的 NLRP3 炎性小体。
Pharmacol Ther. 2022 Aug;236:108053. doi: 10.1016/j.pharmthera.2021.108053. Epub 2021 Dec 11.
本文引用的文献
1
Interleukin-1 blockade in cardiovascular diseases: a clinical update.白细胞介素-1 阻断在心血管疾病中的应用：临床更新。
Eur Heart J. 2018 Jun 7;39(22):2063-2069. doi: 10.1093/eurheartj/ehy128.
2
The NLRP3 inflammasome in acute myocardial infarction.NLRP3 炎性小体与急性心肌梗死。
Nat Rev Cardiol. 2018 Apr;15(4):203-214. doi: 10.1038/nrcardio.2017.161. Epub 2017 Nov 16.
3
HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.心脏结节病相关心律失常诊断与管理的HRS专家共识声明
Heart Rhythm. 2014 Jul;11(7):1305-23. doi: 10.1016/j.hrthm.2014.03.043. Epub 2014 May 9.
4
Significance of the interleukin-1 receptor antagonist/interleukin-1 beta ratio as a prognostic factor in patients with pulmonary sarcoidosis.白细胞介素-1受体拮抗剂/白细胞介素-1β比值作为结节病患者预后因素的意义
Respiration. 2000;67(4):389-96. doi: 10.1159/000029536.
Zotero 插件